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Abstract
Remodelling the methylome is a hallmark of mammalian development and cell differentia-
tion. However, current knowledge of DNA methylation dynamics in human tissue specifica-
tion and organ development largely stems from the extrapolation of studies in vitro and
animal models. Here, we report on the DNA methylation landscape using the 450k array of
four human tissues (amnion, muscle, adrenal and pancreas) during the first and second tri-
mester of gestation (9,18 and 22 weeks). We show that a tissue-specific signature, consti-
tuted by tissue-specific hypomethylated CpG sites, was already present at 9 weeks of
gestation (W9). Furthermore, we report large-scale remodelling of DNA methylation from
W9 to W22. Gain of DNA methylation preferentially occurred near genes involved in general
developmental processes, whereas loss of DNA methylation mapped to genes with tissue-
specific functions. Dynamic DNAmethylation was associated with enhancers, but not
promoters. Comparison of our data with external fetal adrenal, brain and liver revealed strik-
ing similarities in the trajectory of DNAmethylation during fetal development. The analysis
of gene expression data indicated that dynamic DNA methylation was associated with the
progressive repression of developmental programs and the activation of genes involved in
tissue-specific processes. The DNAmethylation landscape of human fetal development
provides insight into regulatory elements that guide tissue specification and lead to organ
functionality.
Author Summary
Methylation of DNA is a key epigenetic mark. Adult tissues have highly distinct genome-
wide DNA methylation signatures. How these signatures arise during human fetal devel-
opment is largely unknown. Here, we studied DNA methylation profiles of four tissues
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Data Availability Statement: Fetal DNA methylation
data have been deposited in the NCBI’s Gene
Expression Omnibus under accession number
GSE56515. External datasets that have been used in
this manuscript include: fetal and adult DNA
methylation data of various tissues from Nazor et al.
(Gene Expression Omnibus (GEO) [69] accession
number: GSE31848) [15], fetal brain DNA
methylation data from Spiers et al. (GEO accession
number: GSE58885) [22], fetal liver DNA methylation
data from Bonder et al. (GEO accession number:
GSE61279) [30], adult DNA methylation data of
various tissues from Slieker et al. (GEO accession
(amnion, muscle, adrenal, pancreas) during first and second trimester of human fetal
development. Already in the first trimester, a tissue-specific signature was found in each of
the tissues. However, during the first and second trimester, a substantial number of geno-
mic regions were found to gain and lose DNAmethylation. Genomic regions that gained
methylation were associated with the shut-down of developmental processes, while geno-
mic regions that lose methylation were associated with the activation of tissue-specific
functions. These findings on the DNA methylation landscape of human fetal development
are important as they provide insight into regulatory elements that guide tissue specifica-
tion and lead to organ functionality.
Introduction
Methylation of CpG dinucleotides in the mammalian genome is a key epigenetic mark. Adult
tissues have highly distinct genome-wide DNAmethylation signatures consistent with the reg-
ulation of cell differentiation by epigenetic mechanisms [1–3]. Differences in DNAmethylation
between tissues have been shown to mark differences between germ layers [4], preferentially at
regions with low CpG content [2,5,6], at enhancers [4] and alternative promoters [7,8].
Multiple studies have reported on the reprogramming of the human methylome during pre-
implantation embryo development [9–11]. In line with previous data on mice [12], in humans
DNAmethylation is largely erased after conception, the paternal genome being actively and
the maternal genome passively demethylated, to become remethylated with the implantation
of the embryo [9,10,13,14]. However, systematic and detailed reports on DNA methylation
dynamics during human fetal development remain scarce [15], while such data is key to under-
stand how epigenetic mechanisms drive tissue specification and organ functionality. Current
views of fetal DNA methylation dynamics are largely extrapolated from studies on the differen-
tiation of human and mouse cells in vitro [7,15–21], and the comparison of differentiated tis-
sues to human induced pluripotent stem cells and human embryonic stem cell lines [15]. An
exception is fetal brain development in humans, for which recently reported in vivo data
showed significant DNA methylation remodelling [15,22].
Recent developments in technology for interrogating genome-wide DNAmethylation at single-
nucleotide resolution [23] and detailed functional annotation of the human genome [24,25] pro-
vide an opportunity to chart DNAmethylation during development and assign biological roles to
the regions involved. Taking advantage of these developments, we report on DNAmethylation
dynamics during human fetal development of one extraembryonic tissue and three organs relevant
for complex human diseases. This organ-specific catalogue of DNAmethylation during develop-
ment provides fundamental insights into processes guiding human development, but also into the
biological function of non-coding regions, which are emerging as important from genome-wide
association studies (GWASs) of complex diseases [26]. In addition, this catalogue may serve as a
reference for studies on the role of epigenetic mechanisms in the association between an adverse
prenatal environment and adulthood disease [27] since DNAmethylation marks may have an
heightened sensitivity for environmental perturbations during remodelling [28].
Results
Fetal DNA methylation reflects tissue origin and developmental age
To study DNAmethylation dynamics in human fetal development, amnion, muscle, adrenal
and pancreas samples of 11 fetuses were obtained at 9, 18 and 22 weeks of gestation (W9, W18
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number: GSE48472) [5], fetal Deep SAGE
expression data of the four tissues studied here from
Roost et al. (GEO accession number: GSE66302)
[40], adult DNA methylation brain data from Pidsley
et al.(GEO accession number: GSE61431) [38],
WGBS data of fetal and adult muscle generated by
the Epigenomics Roadmap consortium (GEO
accession numbers GSM1172596 and
GSM1010986), MYOD binding peaks from
MacQuarrie et al. (GEO accession numbers
GSM1218849 and GSM1218850) [46].
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andW22; S1A Fig). Genome-wide DNAmethylation was investigated with the Illumina 450k
array resulting in data on 452,490 CpG sites after quality control [29] (S1B–S1E Fig). The
study included three biological replicates per tissue and time point, except for W22 amnion
(n = 2) and W22 pancreas (n = 2) (S2A Fig).
We first assessed differences in overall DNA methylation patterns between time points and
tissues using hierarchical clustering based on Euclidean distance (Fig 1A) and multidimen-
sional scaling (MDS) (Figs 1B and S2B). DNA methylation patterns clearly differentiated the
four tissue types studied (Figs 1A, 1B and S2B). The amnion, representing an extraembryonic
tissue, clustered separately from the three embryonic tissues (Fig 1A). Within the embryonic
cluster, all W9 tissues (representative of the first trimester) clustered together, whereas
W18-W22 tissues (representative of the second trimester) were present towards the edges of
the MDS plot (Figs 1B and S2B). Despite the distinct differences in DNA methylation patterns
from the first to second trimester, the total number of hypo-, intermediately and hypermethy-
lated CpGs remained constant across time points and tissues (including the extraembryonic
amnion) on both autosomes and, in females, the X chromosome (S2C and S2D Fig). This sug-
gests that the observed differences in the MDS plot were not driven by changes in average levels
of DNA methylation, but rather due to tissue- and time-specific changes in DNAmethylation.
To validate our findings, we integrated our data with three previously published Illumina
450k datasets on 10 human fetal tissues [15,22,30]. Hierarchical clustering of all data together
(n = 117) confirmed the presence of distinct tissue- and time-specific DNA methylation pat-
terns in fetal tissues (S2E Fig).
The characteristics and biological function of DNA methylation depend on the local CpG
content and position relative to genes [31]. We mapped CpG sites (CpGs) to CpG islands
(CGIs as defined in the UCSC genome browser; 138,919 CpGs), their shores (±2 kb of CGIs;
Fig 1. Tissue- and time-specific DNAmethylation patterns during human fetal development. (A) Clustering based on Euclidean distance. (B)
Multidimensional scaling based on Euclidean distance of the four tissues. (C) Median DNAmethylation for each of the four tissues over time with a combined
genic and CGI-centric annotation. CGI, CpG island.
doi:10.1371/journal.pgen.1005583.g001
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103,453 CpGs) and shelves (±2 kb of shores; 42,227 CpGs), and remaining CpG-poor non-
CGI regions (157,560 CpGs), and to regions relative to gene locations including distal promot-
ers (-10 kb–-1.5 kb; 21,101 CpGs), proximal promoters (-1.5 kb–+0.5 kb; 171,077 CpGs), gene
bodies (+0.5 kb–3’ untranslated region (UTR); 175,062 CpGs), downstream regions (3’ UTR–
+5 kb; 8,563 CpGs) and remaining intergenic regions (66,356 CpGs; Fig 1C). CpGs were com-
monly hypomethylated in CGIs, intermediately methylated in shores and hypermethylated in
both shelves and non-CGI regions (Fig 1C). These patterns differed by genic position, e.g. CGI
methylation was lowest in proximal promoters and highest in gene bodies. Annotation-specific
methylation differences were found between W9 and W22, as CpGs in CGIs and shores tended
to increase (e.g. gene body CGIs and distal promoter shores), whereas CpGs in non-CGI
regions decreased in methylation (e.g. non-CGI promoters). For a subset of annotations, the
amnion showed a slightly different DNAmethylation patterns than for embryonic tissues, e.g.
for gene body CGIs (Fig 1C). Taken together, our data imply that DNAmethylation is highly
dynamic during fetal development without affecting the average level of DNAmethylation.
Hypomethylation discriminates tissues independent of developmental
age
It has been shown that each adult tissue is defined by tissue-specific DNA hypomethylation
[15,32,33]. Since the four fetal tissues analysed showed a clear DNA methylation signature that
corresponded to separated clusters (Fig 1A and 1B), we investigated whether combinations of
tissue-specific DNA hypomethylated CpGs were present irrespective of its developmental
stage. To do this, we identified CpGs that were relatively hypomethylated (defined as a DNA
methylation difference of> 20%) in each tissue compared to all others throughout the three
time points of fetal development investigated. The analysis showed indeed that, independently
of the developmental age, each tissue showed a cluster of tissue-specific hypomethylated CpGs
(Fig 2A). The early lineage segregation of the amnion was further confirmed by the compara-
tively large number of CpGs (3,536 CpGs) that were exclusively hypomethylated across amni-
otic samples. In contrast, the embryonic tissues contained much fewer tissue-specific
hypomethylated CpGs (muscle 756 CpGs; adrenal 140 CpGs; pancreas 220 CpGs) reflecting
their common origin of the epiblast, that gives rise to all embryonic tissues. Genes mapping
(i.e. the nearest gene locus) to the specific hypomethylated CpGs per tissue regardless of the
time point (amnion 2372, muscle 548, adrenal 120, pancreas 175) were enriched for biological
processes that included GO terms characteristic of amnion, muscle and pancreas development
and function (S1 Table).
When annotated to genic and CGI-related location, it became evident that tissue-specific
hypomethylation was enriched for non-CGI regions (P< 0.0001) and highly depleted at CGIs,
in particular when mapping to proximal promoters (P< 0.0001; Figs 2B and S3A). To gain fur-
ther insight in the biological role of genomic regions displaying tissue-specific hypomethyla-
tion, we used chromatin state segmentations for fetal muscle, fetal adrenal, amnion and adult
pancreatic islets generated by the Epigenomics Roadmap [25]. Tissue-specific hypomethylation
was strongly enriched at enhancers (P< 0.001; Figs 2C and S3B). The functional relevance of
those tissue-specific hypomethylated CpGs was further validated by comparison to additional
fetal samples [15] and adult somatic tissues [6] from available external datasets (S3C Fig).
Intriguingly, a high degree of similarity between tissues sharing the same origin, even into
adulthood, was observed (S3C Fig).
We next investigated whether tissue-specific hypomethylated CpGs clustered into Hypo-
methylated Regions (tHRs, defined as 3 consecutive hypomethylated CpGs within 1kb of each
other) [6]. This was the case for amnion, muscle and pancreas (Tables 1 and S2). tHRs
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comprise robust development-independent epigenetic markers as exemplified by the mapping
of pancreatic tHRs to proximal promoters of the nearest genes ACY3,HNF1A, andHNF4A
(Table 1 and S3D Fig), genes with a key role in pancreas development [34,35]. Muscle tHRs (S2
Table) mapped to distal elements of transcription factors involved in muscle development
(NFATC1) and somitogenesis (UNCX) [36,37] (S3D Fig and Tables 1 and S2). Importantly, we
could confirm the tHRs identified with the relatively sparse Illumina 450k array with fetal and
adult muscle whole-genome bisulfite sequencing (WGBS) data (S3E Fig) [25]. These data indi-
cate that it is feasible to use combinations of tHRs as tissue-specific and development-indepen-
dent barcodes.
Distinct roles for gain and loss of DNA methylation in fetal development
We provide evidence for large-scale DNAmethylation dynamics between W9 andW22 (DNA
methylation difference> 20%) that affected 11.5% of evaluated CpGs (52,134/452,490).
Approximately equal numbers of CpGs showed a gain of methylation (GOM) (26,555
Fig 2. Sets of hypomethylated CpG sites are tissue-specific. (A) Heatmap representing hypomethylated CpGs per tissue, defined by a beta difference
of 0.2 of the studied tissue compared to the other tissues. (B) Combined genic and CGI-centric annotation for the hypomethylated CpGs per tissue
represented as the odds ratio (see S3A Fig for odds ratios). CGI, CpG island; DP, distal promoter; DS, downstream; GB, gene body; IG, intergenic; NC, non-
CGI; PP, proximal promoter; SHE, shelves; SHO, shores. (C) Enrichment of hypomethylated CpGs in the chromatin state segmentation states for the
matching tissues (amnion, fetal muscle, fetal adrenal and adult pancreatic islets; see S3B Fig for odds ratios).
doi:10.1371/journal.pgen.1005583.g002
DNAMethylation Landscapes of Human Fetal Development
PLOS Genetics | DOI:10.1371/journal.pgen.1005583 October 22, 2015 5 / 19
CpGs; amnion 5,988; muscle 7,631; adrenal 13,997; pancreas 8,620) and a loss of methylation
(LOM) (25,579 CpGs; amnion 10,811; muscle 11,925; adrenal 4,476; pancreas 3,286) (Fig 3A).
DNAmethylation remodelling occurred predominantly between W9 and W18 and not
between W18 and adulthood (Figs 3B and S4A). Intriguingly, the integration and re-analysis of
external DNA methylation data of fetal adrenal, brain and liver [6,15,22,30,38] revealed a strik-
ing confirmation of DNAmethylation dynamics during fetal development. Furthermore, for
all embryonic tissues, the DNAmethylation levels at W22 were similar to those found in the
adult counterpart (Figs 3B and S4A), suggesting that the extent of changes after W22 are lim-
ited for these CpGs.
GOM CpGs did not show tissue-specific patterns (Fig 3A) and, in line with this observation,
often corresponded to genes involved in generic developmental and cellular processes, includ-
ing embryonic morphogenesis and regulation of transcription (S3 Table). In contrast, the LOM
CpGs were highly tissue-specific (Fig 3A) and mapped to genes involved in tissue-specific pro-
cesses that matched the organ in which the LOM CpGs were identified (S3 Table). CpGs that
lost methylation in the amnion mapped, amongst others, to genes that were associated with the
regulation of apoptosis and cytoskeleton organization; in the muscle to genes associated with
cytoskeleton organization and muscle system processes; in the adrenal to genes associated with
regulation of macromolecule metabolism (S3 Table). In the pancreas no significant enrich-
ments were found.
GOM and LOM CpGs differed in their genomic annotation. While GOM CpGs were gener-
ally enriched in CGIs and CGI-shores, LOM CpGs were enriched for CGI-shelves and non-
CGI regions (Figs 3C and S4B). LOM- and GOM-specific enrichments were also observed for
Epigenomics Roadmap chromatin state segmentations. LOM CpGs were strongly enriched for
(genic) enhancers and transcribed regions, whereas GOM CpGs were enriched for bivalent and
repressed regions and only modestly at enhancers (Figs 3D and S4C). The results underscore
the relevance of DNAmethylation in enhancer activity, in addition to the well-studied relation-
ship between DNAmethylation and promoter activity [39].
We previously reported on transcriptional data of amnion (n = 7), muscle (n = 6), adrenal
(n = 3) and pancreas (n = 7) at W9, W18 andW22 [40] and used this data to test the hypothesis
that GOM is associated with the epigenetic downregulation of developmental programs and
LOM with upregulation of tissue-specific processes. Genes associated with GOM and involved
in embryonic morphogenesis (a process enriched for GOM in all tissues) showed a decrease in
transcriptional activity fromW9 to W22 in all tissues (amnion, muscle, pancreas: P< 0.05;
Table 1. Table with the numbers of tHRs and three representative genes per tissue associated with tHRs. SM, skeletal muscle; TF, transcription
factor.
Tissue Gene Feature Function
Amnion SLC22A2 PP Tubular uptake of organic compounds from circulation
(67 tHRs) VTCN1 PP B7 costimulatory protein family
SLC39A2 PP Zinc, iron, and calcium homeostasis
Muscle UNCX IG TF involved in somitogenesis and neurogenesis
(15 tHRs) NFATC1 IG Involved in SM development/differentiation
DPT PP Extracellular structure organization
Pancreas ACY3 PP Aminoacylase activity
(3 tHRs) HNF1A PP Transcriptional activator
HNF4A PP Transcriptional activator
doi:10.1371/journal.pgen.1005583.t001
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adrenal P = 0.87; Fig 4A). In contrast, genes involved in tissue-specific processes found to be
enriched for LOM (S3 Table) increased in transcription fromW9 to W22 (P< 0.05; Figs 4B
and S4D).
Fig 3. Gain and loss of DNAmethylation during human fetal development. (A) Heatmap of CpGs with a gain and a loss, respectively, of methylation
over time. Gain and loss of methylation was defined as a difference of beta 0.2 betweenW9 andW22, andW18 in between. (B) Mean methylation of CpGs
with a gain or loss of DNAmethylation for fetal tissues and their adult counterpart. (C)Combined genic and CGI-centric annotation for CpGs with a gain or a
loss of methylation represented as the odds ratio (see S4B Fig for odds ratios). CGI, CpG island; DP, distal promoter; DS, downstream; GB, gene body; IG,
intergenic; NC, non-CGI; PP, proximal promoter; SHE, shelves; SHO, shores. (D) Enrichment of dynamically methylated CpGs in the chromatin
segmentation states for the matching tissues (fetal muscle, fetal adrenal, amnion and adult pancreatic islets; see S4C Fig for odds ratios).
doi:10.1371/journal.pgen.1005583.g003
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Altogether, these findings emphasize that DNAmethylation dynamics during human fetal
development is associated with the availability to transcription of both general embryonic pro-
grams (shutting those down for transcription) as well as tissue-specific developmental pro-
grams (making those available for transcription).
Dynamically methylated regions correlate with developmental and
tissue-specific genes
From the dynamically methylated CpGs, we identified 2,229 development-related differentially
methylated regions (dDMRs, defined as 3 consecutive differentially methylated CpGs within
1kb of each other) undergoing GOM (amnion 185; muscle 530; adrenal 1,065; pancreas 449)
and 1,017 undergoing LOM (amnion 388; muscle 482; adrenal 136; pancreas 61; S4 Table).
After mapping the dDMRs to the nearest gene locus we observed that the percentage of com-
mon genes in the embryonic tissues showing LOM dDMRs was 1.3%, whereas those showing
GOM was 10.2% (Fig 5A).
LOM dDMRs were associated with genes involved in tissue-specific functions such as
MYH3 in muscle (muscle contractile protein),MC2R (adrenocorticotropic hormone receptor)
in adrenal and PFKFB3 (involved in insulin secretion) in the pancreas (Table 2 and S5A Fig).
As an example of tissue specificity encountered in the dDMRs showing a loss of DNAmethyla-
tion, we zoomed in on theMYLK2 locus, a muscle-specific gene [41]. The methylation of the
MYLK2 promoter and first exon in the muscle decreased during development, but increased
(or remained constant) in the other organs studied (Fig 5B). Interestingly, GOM dDMRs were
associated with (tissue-specific) developmental genes, such as PAX3 in muscle, a key gene in
myogenesis [42], and NKX6.1 in pancreas, an important gene in beta-cell development [43]
(Table 2 and S5A Fig), but also near well-known developmental genes including theHOXB
Fig 4. DNAmethylation dynamics are accompanied by changes in gene expression. (A) Expression profiles of genes in embryonic morphogenesis
near dynamic regions with gain of methylation represented as median with the interquartile range (IQR) [40]. (B) Expression profiles of genes near dynamic
regions with loss of methylation grouped by significant, tissue-specific Gene Ontology terms for each of the four tissues from S3 Table represented as
median with IQR [40]. Reg., regulation.
doi:10.1371/journal.pgen.1005583.g004
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Fig 5. Association of gain and loss of DNAmethylation, DNAse I hypersensitive sites and histonemodifications. (A) Venn diagram visualizing the
overlaps between genes with a gain and a loss of methylation of the three embryonic tissues. (B) Methylation difference betweenW9 andW22 ofMYLK2 in
the four tissues. (C) Methylation difference betweenW9 andW22 of theHOXB cluster. (D) Mean DNAse I hypersensitive (DHS) and histone modifications
signals in a 5 kb flanking region of the muscle dDMRs in HSMMs and HSMMtubes. HSMM, human skeletal muscle myoblasts; HSMMtube, human skeletal
muscle myotubes.
doi:10.1371/journal.pgen.1005583.g005
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(Fig 5C) and other HOX clusters (S6A Fig) that play a key role in embryonic patterning and
morphogenesis [44].
However, when comparing all identified dDMRs to previously identified adult (tissue-spe-
cific) tDMRs using the 450k array [6], about 50% of the GOM dDMRs were not identified as
tDMRs in adult tissues (S5B Fig), while 32% and 38%, of the LOM dDMRs in muscle and pan-
creas, respectively, were unique for those fetal tissues (adult data on adrenal was absent). The
persistence into adulthood of subsets of GOM and LOM dDMRs was confirmed using WGBS
data for adult muscle [25] (S5C Fig). These results suggest that the study of DNA methylation
dynamics in fetal development will identify regions that are remodelled during development
and are missed when studying adult tissues only.
We further explored the potential biological validity of the 1,012 muscle dDMRs using
ENCODE data [24] on human skeletal muscle myoblasts (HSMMs) and their differentiated
derivatives, human skeletal muscle myotubes (HSMMtubes). In HSMMs and HSMMtubes,
DNAse I hypersensitive sites (DHSs), which mark genomic regions of open chromatin associ-
ated with transcriptional activity, were abundant at LOM dDMRs, particularly in CpG-poor
regions (CGI-shelves and non-CGI regions, Fig 5D left). DHSs were depleted at GOM dDMRs
in CpG-rich regions (CGIs and CGI-shores, Fig 5D left). Consistent with an increased tran-
scriptional activity, LOM dDMRs were also enriched in myotubes and myoblasts (ENCODE
[24]) for histone H3 lysine 4 methylation ((H3K4me1, -me2, -me3) [25,45], and acetylation of
histone H3 at lysine 9 and 27 (H3K9ac, H3K27ac), all marks associated with active regulatory
regions [25,45] (Fig 5D right). In contrast, these active histone modifications were depleted for
GOM dDMRs in CpG-rich regions (Fig 5D right). LOM dDMRs were depleted of H3K9me3
(marking inactive DNA), H3K27me3 (marking Polycomb-repressed regions) and H3K36me3
in HSMMtubes but not in their precursor cells HSMMs (Fig 5D right). A final indication for
the functional relevance of the muscle dDMRs was that 124 out of 482 LOM dDMRs
Table 2. Table with six genes per tissue highlighting the tissue specificity of the genes found near dDMRs with a loss of methylation as well as the
association of dDMRs with a gain of methylation with tissue-specific developmental genes.
Gain of
methylation
Loss of
methylation
Tissue Gene Features Function Gene Features Function
Amnion TNXB GB Cell adhesion TNXB PP/GB Cell adhesion
TFAP2A IG/DP Cell differentiation DIP2C GB Ectoderm development
TFAP2B GB Cell proliferation CD59 PP Lymphocyte signal
transduction
Muscle SIX3 IG/DP/GB/
DS
Transcription factor in repression of
WNT
MYLK2 PP Myosin light chain kinase
HLX DP/GB/DS Homeobox TF factor in muscle
development
MYOZ1 PP Calcineurin signaling in
muscle
PAX3 GB/PP Muscle development MYH3 PP Muscle contractile protein
Adrenal TBX3 IG/DP/DS TF in developmental processes KCNQ1 PP Potassium channel protein
NR2F2 IG/DS Steroid thyroid hormone nuclear
receptor
MC2R PP Adrenocorticotropin receptor
KCNQ1 PP/GB Potassium channel protein SEC14L1 PP Intracellular transport
Pancreas NKX6.1 DP Beta cell development SLC25A22 PP Glucose responsiveness
PROX1 DP Co-repressor of HNF4A FAIM3 PP Promotes β-cell proliferation
PRDM16 GB Transcription factor activity PFKFB3 GB Insulin secretion
doi:10.1371/journal.pgen.1005583.t002
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significantly overlapped (P< 0.0001) with binding sites of the muscle-specific transcription
factorMYOD in HSMMs (188/482 in HSMMtubes), whereas only 7 out of the 530 GOM
dDMRs mapped toMYOD binding sites[46] (8/530 in HSMMtubes; S5D Fig).
Discussion
Here, we show that human tissues already exhibit a specific DNAmethylation signature as
early as W9 of fetal development. In addition, the DNA methylation landscape is subjected to
considerable changes from the first to second trimester of gestation as the developing organs
gain complexity and functionality. Our study highlights that dynamic DNAmethylation is not
only an integral part of early preimplantation embryo development and implantation [9–11],
but continues to be a key feature of epigenetic remodelling during human fetal development.
While global changes in levels of DNA methylation characterize development until implanta-
tion (Fig 6), these are not observed during fetal development. Instead, distinct LOM occurs
near tissue-specific genes and GOM occurs near developmental genes in a largely tissue-inde-
pendent fashion (Fig 6). Our direct assessment of DNAmethylation dynamics suggests that a
larger proportion of the methylome is remodelled during development than previously thought
[3,6,47].
Interestingly, the functional relevance of identified dynamic regions was further exemplified
by the changes in expression of their nearest genes. While the nearest genes of regions gaining
DNAmethylation associated with embryonic morphogenesis showed loss of expression, the
nearest genes of regions losing DNA methylation showed increased expression over time. In
agreement with our observations, LOM of hematopoietic-specific genes has been observed dur-
ing human hematopoietic differentiation in vitro [48] and have been linked to transcriptional
changes in human T-cell development [49]. Moreover, several mouse and human in vitro stud-
ies demonstrated that the methylation of developmental genes increases [19,50] and tissue-spe-
cific functional genes lose methylation [5,51] during stem and progenitor cell differentiation.
Lastly, DNA demethylating agents, such as 5-azacytidine, have been shown to promote stem
cell differentiation and maturation of skeletal myotubes in mice [52,53]. Further experimental
studies are required to evaluate the mechanistic role of DNAmethylation in development.
Although our study reveals general principles of DNAmethylation dynamics during human
fetal development, it should be noted that a limited number of tissues and individuals was
investigated; and that we used a genome-wide method interrogating a relatively small propor-
tion of all CpGs in the human genome. Expansion to more tissues and the application of
whole-methylome technologies will lead to a more comprehensive catalogue of regulatory
regions. However, by extensive inclusion of external fetal and adult 450k array datasets, we
have consolidated our findings. Moreover, the use of external available WGBS data confirmed
the results obtained by the 450k array data.
Fig 6. DNAmethylation dynamics during human development. This illustration depicts the current comprehensive knowledge of DNAmethylation during
human pre- and postimplantation development. The knowledge about DNAmethylation during human preimplantation (left panel) is derived from [9–12]
whereas our study sheds light on postimplantation development (right panel).
doi:10.1371/journal.pgen.1005583.g006
DNAMethylation Landscapes of Human Fetal Development
PLOS Genetics | DOI:10.1371/journal.pgen.1005583 October 22, 2015 11 / 19
Since we studied organ biopsies similar to previous studies investigating biopsies of human
adult tissues [3,15], the methylation profiles we report reflect the average of multiple cell types.
The cellular complexity of the organs investigated led to an underestimation of the actual DNA
methylation dynamics in individual cell types. This is exemplified by the detection of a consid-
erably larger number of CpGs displaying dynamic methylation in muscle which has an exclu-
sive mesodermal origin in comparison with adrenal and pancreas which are composed by cells
originating from two different germ layers (adrenal: mesoderm and ectoderm (neural crest);
pancreas: endoderm and mesoderm). However, it is unlikely that the methylation dynamics
observed is an epiphenomenon of this cellular complexity instead of being driven by cell differ-
entiation and maturation. This is obvious for genes associated with GOM that appears to be
shared across organs to repress general developmental programs during development. In con-
trast, genes associated with LOM displayed tissue-specific patterns. Their intricate involvement
in organ-specific functions was emphasized by tight linkage to biological processes and chro-
matin states relevant to the organs investigated. Moreover, between W9 and W22, the organs
analysed are mainly composed of progenitor cells; perfusion by blood and lymphatic vascula-
ture, and innervation by neural crest cell derivatives still plays a minor role as compared
with adult organs (S1A Fig). In the future, single-cell methodology [54,55] will enable compar-
ing single-cell DNA methylomes of the various adult cell types to their fetal progenitor
counterparts.
Studies of DNAmethylation landscapes of human fetal development may serve as reference
in the development of (organoid) differentiation models [56] and, moreover, shed light on
potential mechanisms underlying genetic associations and studies in the field of epigenetic epi-
demiology [57] focussing on the prenatal environment.
Materials and Methods
Ethical statement
The Medical Ethical Committee of the Leiden University Medical Center approved this study
(P08.087). Informed consent was obtained on the basis of the Declaration of Helsinki (World
Medical Association).
Fetal tissue
Human fetal tissues (amnion, skeletal muscle, adrenal glands, pancreas) at gestational age W9,
W18, W22 (S2A Fig) were collected from elective abortion material (vacuum aspiration) with-
out medical indication. In this study, “weeks of gestation” was used as determined by the last
menstrual period (LMP). After collection, the material was washed with 0.9% NaCl (Fresenius
Kabi, France) and the identified organs were immediately snap-frozen using dry ice and stored
at -80°C until further processing. Histology was performed as previously described [58]. The
images were taken with an Olympus AX70 microscope (Olympus, Japan) provided with a
XC50 digital colour camera (Olympus, Japan).
DNA extraction
Tissues were homogenized with a pestle and lysed overnight at 56°C with proteinase K (600
mAU/ml, Qiagen, Germany) in ATL buffer (Qiagen, Germany). After lysis, residual RNA in
the samples was degraded using RNase A (10 mg/μl, Invitrogen, USA). Subsequently, genomic
DNA (gDNA) was extracted on the basis of phenol/chloroform. Briefly, lysates were trans-
ferred to Phase Lock Heavy Gel 2ml Eppendorf tubes (5PRIME, Germany) and 700 μl of
25:24:1 Phenol/Chloroform/Isoamyl alcohol was added and spun down for 5 minutes. The
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aqueous phase was transferred to a Phase Lock tube and the latter step was repeated. The aque-
ous phase was transferred to a new Phase Lock tube and 700 μl 24:1 Chloroform/Isoamyl alco-
hol was added and spun down for 5 minutes. The aqueous phase was transferred to a Phase
Lock tube and the latter step was repeated. The aqueous phase was transferred to a new 2 μl
Eppendorf tube (Eppendorf AG, Germany), 70 μl 3M sodium acetate (Ambion, USA) and
1400 μl ice cold 100% ethanol were added. gDNA was precipitated over night at -20°C. Eppen-
dorf tubes were spun down at 4°C for 15 minutes and washed twice with 70% ethanol. After
the pellet was dry, gDNA was solubilized in AE buffer (Qiagen, Germany) and stored at 4°C.
DNA concentration was determined using the Qubit dsDNA BR Assay Kit on a Qubit 2.0 Fluo-
rometer (Invitrogen, USA). gDNA was bisulfite converted using the EZ-96 DNA methylation
kit (Zymo Research, Orange County, USA) with an average input of 600 ng gDNA. Following
bisulfite conversion, DNAmethylation data was generated using Illumina HumanMethyla-
tion450 BeadChip according to the manufacturer’s protocol.
(Pre-) processing of the Illumina 450k BeadChip data
All analyses were performed using R statistics, version 3.0.1. The 65 polymorphic SNP probes
featured on the 450k array were used to exclude potential sample mix ups. Data was imported
in R usingminfi [59] and processed and normalized using a custom pipeline: Arrays were
removed if they had a low median intensity, a high background signal or with incomplete bisul-
fite conversion, but none were excluded (S1B, S1C and S1D Fig). The CpGs on chromosome X
and Y were used to confirm sex (S1C Fig). Next, probes with a low bead count (< 3), high
detection P-value (> 0.01), and with a low success rate (< 95%), and ambiguously mapped
probes [60] were removed. After probe filtering, all arrays contained> 95% of the original
number of probes. Background correction and colour correction were applied and the data was
quantile normalized (lumi [61]). To adjust for the type I/II bias BMIQ was applied [62]. In our
analyses, CpG sites in the sex chromosomes (Y and X) were excluded. High correlation was
found between samples from the same time point and tissue but also between time points of
the same tissue (S1D Fig). To exclude chromosomal abnormalities, we calculated the copy
number aberration based on the signal intensities using the method published by Feber et al.
[63] as implemented in the R package ChAMP [64]. From these results, no abnormalities were
found in the samples used (S1E Fig).
Bioinformatics analyses
Multidimensional scaling and clustering was performed based on Euclidean distance. For the
DNAmethylation over time within features, a genic annotation was combined with a CGI-cen-
tric annotation as presented before [6] to determine the median methylation per combined fea-
ture. P were calculated using quantile regression based on the median (R package quantreg
[65]). Figures were made using the R-packages ggplot2 [66] and GenomeGraphs [67].
Tissue-specific hypomethylation: CpGs with a standard deviation 0.1 within the tissue of
interest were discarded. Relative tissue-specific hypomethylation was defined as hypomethyla-
tion of the tissue of interest compared to the other tissues, with a difference of 0.20 in beta
value. CpGs sites were selected if a difference was consistent in each of the time points.
Dynamic methylation: CpGs with a high standard deviation 0.10 within time point/tissues
indicative of an instable estimate of DNAmethylation were discarded from this analysis. Gain
and loss of methylation was defined a gain/loss of 0.20 between W9 andW22 and W18 in
between the two time points (W18 was allowed to be 0.05 lower/higher in beta value than W9/
W22 respectively). The CpGs with a gain or a loss of methylation were used for the combined
genic/CGI-centric annotation and expressed as an odds ratio. Chromatin state segmentation
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data [25] were downloaded from the Epigenomics Roadmap Project for fetal muscle (W15
female), fetal adrenal (W13 male), amnion (W16 male) and pancreatic islets (adult) and
enrichment of dynamically methylated CpGs was calculated.
DMRs: In both, the relative hypomethylated CpGs (tHRs) and the CpGs with a gain or a
loss of methylation (dDMRs), DMRs were called using an algorithm described before [6].
Briefly, DMRs (tHRs and dDMRs) were defined by three consecutive CpGs that matched a cri-
terion (that is, relative hypomethylation or gain/loss of methylation) with a maximum of 1 kb
between CpGs and with at highest three CpGs that did not match the criterion.
Gene ontology: Tissue-specific hypomethylated and dynamically methylated CpGs were
mapped to their nearest gene (that is to the nearest TSS or TES of a gene) and tested for enrich-
ment of gene ontology terms using DAVID [68]. For the tissue-specific hypomethylation we
used a P cut-off of 0.05 on the raw P as the number of CpGs was relatively low. For the dynami-
cally methylated CpGs a FDR cut-off of 0.05 was set as cut-off for enrichment in GO terms. A
background set was used containing nearest genes of all CpGs covered on the array.
Gene expression data: Transcriptional data of the four tissues at W9, W18, W22 (amnion:
n = 2, 3, 2, muscle: n = 2, 2, 2; adrenal: n = 1, 1, 1; pancreas: n = 3, 2, 2) were used. The counts
per million (CPM) expression levels were calculated using the R package edgeR 3.2.4 [69,70].
For the plots, the arithmetic mean of the biological replicates was used and the median of all
genes plotted. To access enrichment of up- and downregulation, a probability test was used.
MYOD, DNAse I, histone marks and WGBS: Overlaps betweenMYOD binding peaks and
muscle dDMRs were calculated. To test for significance, we calculated an empirical distribution
by performing 20,000 permutations with 482 (gain of methylation) and 530 (loss of methyla-
tion) DMR-like regions each and determined the overlap with theMYOD binding sites. DMR-
like regions were defined as regions with equal characteristics as dDMRs identified: an inter-
CpG distance smaller than 1 kb and an average length of five CpGs per DMR-like region (n~8
x 104 regions). The two-sided P was determined using the empirical distribution.
DNAse I and histone mark data of human skeletal muscle myoblasts (HSMMs) and human
skeletal muscle myotubes (HSMMtubes) were downloaded from the ENCODE website [24].
DNAse I hypersensitivity was expressed as the count of DNAse-seq tags. The enrichment of
histone marks was expressed as the log2 of the ChIP/input. The total number of reads within
the myotubes was different from the total number of reads in the myoblast data and, therefore,
the data was normalized. dDMRs were classified as island (CGIs and their shores) or non-
island dDMRs, and DNAse-seq tags and histone marks around dDMRs were mapped up to 5
kb up- and downstream.
CpG sites of WGBS data were mapped to hypomethylated and dynamic regions and their
5kb flanking regions. Using a smooth spline, the methylation around the regions was smoothed
for the adult and fetal data.
Accession numbers
Methylation data has been deposited in the NCBI’s Gene Expression Omnibus [71] under
accession number GSE56515. External datasets that have been used in this manuscript
include: fetal and adult DNAmethylation data of various tissues from Nazor et al. (Gene
Expression Omnibus (GEO) accession number: GSE31848) [15], fetal brain DNAmethylation
data from Spiers et al. (GEO accession number: GSE58885) [22], fetal liver DNA methylation
data from Bonder et al. (GEO accession number: GSE61279) [30], adult DNA methylation
data of various tissues from Slieker et al. (GEO accession number: GSE48472) [6], fetal Deep
SAGE expression data of the four tissues studied here from Roost et al. (GEO accession num-
ber: GSE66302) [40], adult DNA methylation brain data from Pidsley et al.(GEO accession
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number: GSE61431) [38], WGBS data of fetal and adult muscle generated by the Epigenomics
Roadmap consortium (GEO accession numbers: GSM1172596 and GSM1010986), MYOD
binding peaks from MacQuarrie et al. (GEO accession numbers: GSM1218849 and
GSM1218850) [46].
Supporting Information
S1 Fig. Quality control. (A) Histology of the four tissues used in this study during develop-
ment stained with Haematoxylin and Eosin (H&E). White arrow points to first trimester mus-
cle. Scale bars: 100 μm. (B) Density plot of the data per sample coloured by tissue. (C) Density
plot of the sex chromosomes. (D) Pearson correlation between the biological replicates. The
highest correlation was found between tissues and time points. (E) Assessment of chromo-
somal abnormalities.
(JPG)
S2 Fig. General description of tissue-specific DNAmethylation signatures. (A) Table of the
fetal samples included in this study. (B) Multidimensional scaling based on Euclidean distance,
from left to right: coloured by tissue, time point and individual. (C) Autosomal DNAmethyla-
tion in three classes (0%-25%; 25%-75%, 75–100%). (D) DNAmethylation of the X chromo-
some in female samples. (E)Hierarchical clustering of the current data with external fetal data
of various tissues [15,22,30].
(JPG)
S3 Fig. Tissue-specific hypomethylated CpGs and tHRs. (A) The odds ratios of hypomethy-
lated CpGs per tissue in a combined genic and CGI-centric annotation (Fig 2B). (B) The odds
ratios of hypomethylated CpGs per tissue in the chromatin state segmentations of amnion,
fetal muscle, fetal adrenal and adult pancreatic islets (Fig 2C). (C) Comparison of hypomethy-
lated CpGs per tissue in fetal and adult external data [6,15]. (D) Heatmap representing DNA
methylation levels of identified tHRs in amnion, muscle and pancreas in Table 1. (E) WGBS
DNAmethylation profile near hypomethylated regions in muscle of fetal against adult muscle
[25].
(JPG)
S4 Fig. Dynamic DNAmethylation during development. (A) Mean methylation of CpGs
with a gain or loss of DNAmethylation for fetal tissues and their adult counterpart, including
fetal brain and fetal liver [6,15,22,38]. (B) The enrichment of dynamically methylated CpGs in
a combined genic and CGI-centric annotation (Fig 3C), significant odds ratios (Chi-squared
test P< 0.05) are depicted in black. (C) The enrichment of dynamically methylated CpGs in
the chromatin state segmentations of amnion, fetal muscle, fetal adrenal and adult pancreatic
islets (Fig 3D). (D) Expression profiles of genes near dynamic regions with loss of methylation
grouped by the Gene Ontology terms for each of the four tissues from S3 Table [40].
(JPG)
S5 Fig. Dynamic CpGs cluster into development-related DMRs. (A) Average DNA methyla-
tion levels of the genes from Table 2. (B) Overlap between identified dynamic and hypomethy-
lated regions per tissue and adult tDMRs expressed as percentage overlap. (C) WGBS DNA
methylation profile near regions with gain and loss of methylation in muscle of fetal against
adult muscle [25]. (D) Number ofMYOD binding sites relative to the dynamic regions identi-
fied in HSMMs and HSMMtubes. HSMMtube, human skeletal muscle myotube.
(JPG)
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S6 Fig. Dynamic DNAmethylation in the HOX clusters. (A) DNA methylation patterns in
the four developmental HOX clusters HOXA, HOXB, HOXC and HOXD. The bottom heat-
map of each cluster zooms in on a smaller genomic region.
(JPG)
S1 Table. GO enrichment of hypomethylated CpGs per tissue.
(XLSX)
S2 Table. Genes associated with tHRs.
(XLSX)
S3 Table. GO enrichment of CpGs with a gain/loss of DNAmethylation.
(XLSX)
S4 Table. Genes associated with dDMRs with gain and loss of DNAmethylation.
(XLSX)
Author Contributions
Conceived and designed the experiments: SMCdSL BTHMSR RCS FC EJPdK PES. Performed
the experiments: MSR LvI EWT HEDS RCS. Analyzed the data: RCS MSR BTH SMCdSL.
Wrote the paper: RCS MSR BTH SMCdSL.
References
1. Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, Laird PW, et al. Epigenetic profiling of
somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNAmethyla-
tion patterns. HumMol Genet. 2009; 18: 4808–4817. doi: 10.1093/hmg/ddp445 PMID: 19776032
2. Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Gräf S, et al. An integrated resource for
genome-wide identification and analysis of human tissue-specific differentially methylated regions
(tDMRs). Genome Res. 2008; 18: 1518–1529. doi: 10.1101/gr.077479.108 PMID: 18577705
3. Ziller MJ, Gu H, Müller F, Donaghey J, Tsai LT- Y, Kohlbacher O, et al. Charting a dynamic DNAmethyl-
ation landscape of the human genome. Nature. Nature Publishing Group, a division of Macmillan Pub-
lishers Limited. All Rights Reserved.; 2013; 500: 477–81. doi: 10.1038/nature12433 PMID: 23925113
4. Hon GC, Rajagopal N, Shen Y, McCleary DF, Yue F, Dang MD, et al. Epigenetic memory at embryonic
enhancers identified in DNAmethylation maps from adult mouse tissues. Nat Genet. Nature Publishing
Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2013; 45: 1198–206. doi: 10.
1038/ng.2746 PMID: 23995138
5. Nagae G, Isagawa T, Shiraki N, Fujita T, Yamamoto S, Tsutsumi S, et al. Tissue-specific demethylation
in CpG-poor promoters during cellular differentiation. HumMol Genet. 2011; 20: 2710–2721. doi: 10.
1093/hmg/ddr170 PMID: 21505077
6. Slieker RC, Bos SD, Goeman JJ, Bovée JV, Talens RP, van der Breggen R, et al. Identification and
systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array.
Epigenetics Chromatin. 2013; 6: 26. doi: 10.1186/1756-8935-6-26 PMID: 23919675
7. Gifford C a, Ziller MJ, Gu H, Trapnell C, Donaghey J, Tsankov A, et al. Transcriptional and epigenetic
dynamics during specification of human embryonic stem cells. Cell. Elsevier Inc.; 2013; 153: 1149–
1163. doi: 10.1016/j.cell.2013.04.037 PMID: 23664763
8. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D’Souza C, Fouse SD, et al. Conserved role of
intragenic DNAmethylation in regulating alternative promoters. Nature. Nature Publishing Group;
2010; 466: 253–257. doi: 10.1038/nature09165 PMID: 20613842
9. Smith ZD, Chan MM, Humm KC, Karnik R, Mekhoubad S, Regev A, et al. DNAmethylation dynamics
of the human preimplantation embryo. Nature. Nature Publishing Group, a division of Macmillan Pub-
lishers Limited. All Rights Reserved.; 2014; 511: 611–615. doi: 10.1038/nature13581 PMID: 25079558
10. Guo H, Zhu P, Yan L, Li R, Hu B, Lian Y, et al. The DNAmethylation landscape of human early
embryos. Nature. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights
Reserved.; 2014; 511: 606–10. doi: 10.1038/nature13544 PMID: 25079557
DNAMethylation Landscapes of Human Fetal Development
PLOS Genetics | DOI:10.1371/journal.pgen.1005583 October 22, 2015 16 / 19
11. Okae H, Chiba H, Hiura H, Hamada H, Sato A, Utsunomiya T, et al. Genome-wide analysis of DNA
methylation dynamics during early human development. Oakey RJ, editor. PLoS Genet. 2014; 10:
e1004868. doi: 10.1371/journal.pgen.1004868 PMID: 25501653
12. Seisenberger S, Peat JR, Hore TA, Santos F, DeanW, Reik W. Reprogramming DNAmethylation in
the mammalian life cycle: building and breaking epigenetic barriers. Philos Trans R Soc Lond B Biol
Sci. 2013; 368: 20110330. doi: 10.1098/rstb.2011.0330 PMID: 23166394
13. Smith ZD, Chan MM, Mikkelsen TS, Gu H, Gnirke A, Regev A, et al. A unique regulatory phase of DNA
methylation in the early mammalian embryo. Nature. Nature Publishing Group; 2012. pp. 339–344. doi:
10.1038/nature10960 PMID: 22456710
14. Seisenberger S, Andrews S, Krueger F, Arand J, Walter J, Santos F, et al. The Dynamics of Genome-
wide DNAMethylation Reprogramming in Mouse Primordial Germ Cells. Mol Cell. 2012; 48: 849–862.
doi: 10.1016/j.molcel.2012.11.001 PMID: 23219530
15. Nazor KL, Altun G, Lynch C, Tran H, Harness J V., Slavin I, et al. Recurrent variations in DNAmethyla-
tion in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell. 2012; 10: 620–
634. doi: 10.1016/j.stem.2012.02.013 PMID: 22560082
16. Bocker MT, Hellwig I, Breiling A, Eckstein V, Ho AD, Lyko F. Genome-wide promoter DNAmethylation
dynamics of human hematopoietic progenitor cells during differentiation and aging. Blood. 2011; 117:
e182–9. doi: 10.1182/blood-2011-01-331926 PMID: 21427290
17. Xie W, Schultz MD, Lister R, Hou Z, Rajagopal N, Ray P, et al. Epigenomic Analysis of Multilineage Dif-
ferentiation of Human Embryonic Stem Cells. Cell. Elsevier Inc.; 2013; 153: 1134–1148. doi: 10.1016/j.
cell.2013.04.022 PMID: 23664764
18. Brunner AL, Johnson DS, Kim SW, Valouev A, Reddy TE, Neff NF, et al. Distinct DNAmethylation pat-
terns characterize differentiated human embryonic stem cells and developing human fetal liver.
Genome Res. 2009; 19: 1044–1056. doi: 10.1101/gr.088773.108 PMID: 19273619
19. Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong CT, et al. Dynamic changes in the human methy-
lome during differentiation. Genome Res. 2010; 20: 320–331. doi: 10.1101/gr.101907.109 PMID:
20133333
20. Bock C, Beerman I, Lien WH, Smith ZD, Gu H, Boyle P, et al. DNAMethylation Dynamics during In
Vivo Differentiation of Blood and Skin Stem Cells. Mol Cell. 2012; 47: 633–647. doi: 10.1016/j.molcel.
2012.06.019 PMID: 22841485
21. Gilsbach R, Preissl S, Grüning BA, Schnick T, Burger L, Benes V, et al. Dynamic DNAmethylation
orchestrates cardiomyocyte development, maturation and disease. Nat Commun. Nature Publishing
Group; 2014; 5: 5288. doi: 10.1038/ncomms6288 PMID: 25335909
22. Spiers H, Hannon E, Schalkwyk LC, Smith R, Wong CCY, O’Donovan MC, et al. Methylomic trajecto-
ries across human fetal brain development. Genome Res. 2015; 25: 338–352. doi: 10.1101/gr.180273.
114 PMID: 25650246
23. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, et al. High density DNAmethylation array with
single CpG site resolution. Genomics. Elsevier Inc.; 2011; 98: 288–295. doi: 10.1016/j.ygeno.2011.07.
007 PMID: 21839163
24. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, et al. An integrated encyclopedia of
DNA elements in the human genome. Nature. Nature Publishing Group, a division of Macmillan Pub-
lishers Limited. All Rights Reserved.; 2012. pp. 57–74. doi: 10.1038/nature11247 PMID: 22955616
25. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, et al. Mapping and analysis of
chromatin state dynamics in nine human cell types. Nature. 2011; 473: 43–49. doi: 10.1038/
nature09906 PMID: 21441907
26. Hou L, Zhao H. A review of post-GWAS prioritization approaches [Internet]. Frontiers in Genetics.
2013. p. 280. doi: 10.3389/fgene.2013.00280 PMID: 24367376
27. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu
Rev Nutr. Annual Reviews; 2007; 27: 363–88. Available: http://www.annualreviews.org/doi/abs/10.
1146/annurev.nutr.27.061406.093705 PMID: 17465856
28. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al. Persistent epigenetic differ-
ences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A. 2008; 105:
17046–17049. doi: 10.1073/pnas.0806560105 PMID: 18955703
29. Sandoval J, Heyn HA, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al. Validation of a DNA
methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 2011; 6: 692–702.
PMID: 21593595
30. Bonder MJ, Kasela S, Kals M, TammR, Lokk K, Barragan I, et al. Genetic and epigenetic regulation of
gene expression in fetal and adult human livers. BMCGenomics. 2014; 15: 860. doi: 10.1186/1471-
2164-15-860 PMID: 25282492
DNAMethylation Landscapes of Human Fetal Development
PLOS Genetics | DOI:10.1371/journal.pgen.1005583 October 22, 2015 17 / 19
31. Jones PA. Functions of DNAmethylation: islands, start sites, gene bodies and beyond. Nat Rev Genet.
Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2012; 13:
484–92. doi: 10.1038/nrg3230 PMID: 22641018
32. Colaneri A, Wang T, Pagadala V, Kittur J, Staffa NG, Peddada SD, et al. A Minimal Set of Tissue-Spe-
cific Hypomethylated CpGs Constitute Epigenetic Signatures of Developmental Programming. Defos-
sez P-A, editor. PLoS One. 2013; 8: e72670. doi: 10.1371/journal.pone.0072670 PMID: 24069155
33. Song F, Mahmood S, Ghosh S, Liang P, Smiraglia DJ, Nagase H, et al. Tissue specific differentially
methylated regions (TDMR): Changes in DNAmethylation during development. Genomics. 2009; 93:
130–139. doi: 10.1016/j.ygeno.2008.09.003 PMID: 18952162
34. Oliver-Krasinski JM, Stoffers D a. On the origin of the β cell. Genes and Development. 2008. pp. 1998–
2021. doi: 10.1101/gad.1670808 PMID: 18676806
35. Brink C. Promoter elements in endocrine pancreas development and hormone regulation. Cell Mol Life
Sci. 2003; 60: 1033–1048. PMID: 12861373
36. Leitges M, Neidhardt L, Haenig B, Herrmann BG, Kispert a. The paired homeobox gene Uncx4.1 speci-
fies pedicles, transverse processes and proximal ribs of the vertebral column. Development. 2000; 127:
2259–67. PMID: 10804169
37. Schulz R a, Yutzey KE. Calcineurin signaling and NFAT activation in cardiovascular and skeletal mus-
cle development. Developmental Biology. 2004. pp. 1–16. PMID: 14729474
38. Pidsley R, Viana J, Hannon E, Spiers H, Troakes C, Al-Saraj S, et al. Methylomic profiling of human
brain tissue supports a neurodevelopmental origin for schizophrenia. Genome Biol. 2014; 15: 483.
PMID: 25347937
39. Wiench M, John S, Baek S, Johnson TA, Sung M-H, Escobar T, et al. DNAmethylation status predicts
cell type-specific enhancer activity. EMBO J. 2011; 30: 3028–3039. doi: 10.1038/emboj.2011.210
PMID: 21701563
40. Roost MS, van Iperen L, Ariyurek Y, Buermans HP, Arindrarto W, Devalla HD, et al. KeyGenes, a Tool
to Probe Tissue Differentiation Using a Human Fetal Transcriptional Atlas. Stem cell reports. 2015; 4:
1112–24. doi: 10.1016/j.stemcr.2015.05.002 PMID: 26028532
41. Stull JT, Kamm KE, Vandenboom R. Myosin light chain kinase and the role of myosin light chain phos-
phorylation in skeletal muscle. Archives of Biochemistry and Biophysics. 2011. pp. 120–128. doi: 10.
1016/j.abb.2011.01.017 PMID: 21284933
42. Bismuth K, Relaix F. Genetic regulation of skeletal muscle development. Experimental Cell Research.
2010. pp. 3081–3086. doi: 10.1016/j.yexcr.2010.08.018 PMID: 20828559
43. Nelson SB, Schaffer AE, Sander M. The transcription factors Nkx6.1 and Nkx6.2 possess equivalent
activities in promoting beta-cell fate specification in Pdx1+ pancreatic progenitor cells. Development.
2007; 134: 2491–2500. PMID: 17537793
44. Heffer A, Pick L. Conservation and variation in Hox genes: how insect models pioneered the evo-devo
field. Annu Rev Entomol. Annual Reviews; 2013; 58: 161–79. doi: 10.1146/annurev-ento-120811-
153601 PMID: 23317041
45. Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of
mammalian genomes. Nat Rev Genet. 2011; 12: 7–18. doi: 10.1038/nrg2905 PMID: 21116306
46. MacQuarrie KL, Yao Z, Fong AP, Diede SJ, Rudzinski ER, Hawkins DS, et al. Comparison of genome-
wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional
and local suppression of promyogenic transcription factors. Mol Cell Biol. 2013; 33: 773–84. doi: 10.
1128/MCB.00916-12 PMID: 23230269
47. Lokk K, Modhukur V, Rajashekar B. DNAmethylome profiling of human tissues identifies global and tis-
sue-specific methylation patterns. Genome . . .. 2014; Available: http://www.biomedcentral.com/
content/pdf/gb-2014-15-4-r54.pdf
48. Calvanese V, Fernández AF, Urdinguio RG, Suárez-Alvarez B, Mangas C, Pérez-García V, et al. A pro-
moter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res. 2012;
40: 116–131. doi: 10.1093/nar/gkr685 PMID: 21911366
49. Rodriguez R. Regulation of the transcriptional program by DNAmethylation during human αβ T-cell
development. Nucleic acids . . .. 2014; Available: http://nar.oxfordjournals.org/content/early/2014/12/
24/nar.gku1340.short
50. Kim M, Park YK, Kang TW, Lee SH, Rhee YH, Park JL, et al. Dynamic changes in DNAmethylation
and hydroxymethylation when hES cells undergo differentiation toward a neuronal lineage. HumMol
Genet. 2014; 23: 657–667. doi: 10.1093/hmg/ddt453 PMID: 24087792
51. Miyata K, Miyata T, Nakabayashi K, Okamura K, Naito M, Kawai T, et al. DNAmethylation analysis of
human myoblasts during in vitro myogenic differentiation: de novo methylation of promoters of muscle-
DNAMethylation Landscapes of Human Fetal Development
PLOS Genetics | DOI:10.1371/journal.pgen.1005583 October 22, 2015 18 / 19
related genes and its involvement in transcriptional down-regulation. HumMol Genet. 2015; 24: 410–
23. doi: 10.1093/hmg/ddu457 PMID: 25190712
52. Zhou Y, Hu Z. Genome-Wide Demethylation by 5-aza-2’-Deoxycytidine Alters the Cell Fate of Stem/
Progenitor Cells. Stem Cell Reviews and Reports. 2014.
53. Hupkes M, JonssonMKB, ScheenenWJ, van RotterdamW, Sotoca AM, van Someren EP, et al. Epige-
netics: DNA demethylation promotes skeletal myotube maturation [Internet]. The FASEB Journal.
2011. pp. 3861–3872. doi: 10.1096/fj.11-186122 PMID: 21795504
54. Smallwood SA, Lee HJ, Angermueller C, Krueger F, Saadeh H, Peat J, et al. Single-cell genome-wide
bisulfite sequencing for assessing epigenetic heterogeneity. Nat Methods. 2014; 11: 817–20. doi: 10.
1038/nmeth.3035 PMID: 25042786
55. Shapiro E, Biezuner T, Linnarsson S. Single-cell sequencing-based technologies will revolutionize
whole-organism science. Nat Rev Genet. 2013; 14: 618–30. doi: 10.1038/nrg3542 PMID: 23897237
56. Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using orga-
noid technologies. Science. 2014; 345: 1247125. doi: 10.1126/science.1247125 PMID: 25035496
57. Mill J, Heijmans BT. From promises to practical strategies in epigenetic epidemiology. Nat Rev Genet.
2013; 14: 585–94. doi: 10.1038/nrg3405 PMID: 23817309
58. Roost MS, van Iperen L, de Melo Bernardo A, Mummery CL, Carlotti F, de Koning EJ, et al. Lymphan-
giogenesis and angiogenesis during human fetal pancreas development. Vasc Cell. BioMed Central
Ltd; 2014; 6: 22. doi: 10.1186/2045-824X-6-22 PMID: 25785186
59. Hansen KD, Aryee M. minfi: Analyze Illumina’s 450k methylation arrays. R package version 1.6.0. Bio-
conductor; 2013.
60. Chen Y, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al. Discovery of cross-
reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epi-
genetics. 2013; 8: 203–9. doi: 10.4161/epi.23470 PMID: 23314698
61. Du P, KibbeWA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008; 24:
1547–8. doi: 10.1093/bioinformatics/btn224 PMID: 18467348
62. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture
quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNAmethyla-
tion data. Bioinformatics. 2013; 29: 189–96. doi: 10.1093/bioinformatics/bts680 PMID: 23175756
63. Feber A, Guilhamon P, Lechner M, Fenton T, Wilson GA, Thirlwell C, et al. Using high-density DNA
methylation arrays to profile copy number alterations. Genome Biol. 2014; 15: R30. doi: 10.1186/gb-
2014-15-2-r30 PMID: 24490765
64. Morris TJ, Butcher LM, Feber A, Teschendorff AE, Chakravarthy AR, Wojdacz TK, et al. ChAMP: 450k
Chip Analysis Methylation Pipeline. Bioinformatics. 2014; 30: 428–430. doi: 10.1093/bioinformatics/
btt684 PMID: 24336642
65. Koenker R. quantreg: Quantile Regression [Internet]. 2013. Available: http://cran.r-project.org/
package=quantreg
66. Wickham H. ggplot2: elegant graphics for data analysis. Springer, New York. Springer, New York;
2009.
67. Durinck S, Bullard J. GenomeGraphs: Plotting genomic information from Ensembl. R package version
1.22.0.
68. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using
DAVID bioinformatics resources. Nat Protoc. Nature Publishing Group; 2009; 4: 44–57. doi: 10.1038/
nprot.2008.211 PMID: 19131956
69. Robinson MD, McCarthy DJ, Smyth GK. edgeR: A Bioconductor package for differential expression
analysis of digital gene expression data. Bioinformatics. 2009; 26: 139–140. doi: 10.1093/
bioinformatics/btp616 PMID: 19910308
70. Robinson MD, Smyth GK. Small-sample estimation of negative binomial dispersion, with applications
to SAGE data. Biostatistics. 2008; 9: 321–32. Available: http://biostatistics.oxfordjournals.org/content/
9/2/321.short PMID: 17728317
71. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: Archive for
functional genomics data sets—Update. Nucleic Acids Res. 2013; 41: D991–5. doi: 10.1093/nar/
gks1193 PMID: 23193258
DNAMethylation Landscapes of Human Fetal Development
PLOS Genetics | DOI:10.1371/journal.pgen.1005583 October 22, 2015 19 / 19
Reproduced with permission of the copyright owner. Further reproduction prohibited without
permission.
